Methods: Longitudinal studies with ≥ 75 participants who had suffered or were at risk of stroke or TIA, and which evaluated cognitive function were invited to join STROKOG. The consortium will facilitate projects investigating rates and patterns of cognitive decline, risk factors for VCD, and biomarkers of vascular dementia.
Results: Currently STROKOG includes 25 (21 published) studies, with 12,092 participants from 5 continents. The duration of follow up ranges from 3 months to 21 years.
Discussion: While data harmonisation will be a key challenge, STROKOG is in a unique position to reuse and combine international cohort data and fully explore patient level characteristics and outcomes. STROKOG could potentially transform our understanding of VCD and have a worldwide impact on promoting better vascular cognitive outcomes.
|Journal||Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring|
|Early online date||18 Nov 2016|
|Publication status||E-pub ahead of print - 18 Nov 2016|